In accordance with applicable privacy legislation, the company Kedrion S.p.a., controller of the data acquired via this website, hereby informs the user that said website does not use profiling cookies to send advertising messages tuned to preferences expressed when browsing the internet. This website installs third party cookies. Continuing to browse, including by scrolling down and clicking on website elements, equates to consent.
For more information, also as regards the technical cookies used by the website and to refuse consent to the installation of individual cookies, please refer to the complete cookies disclosure.
You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
-
EVENTS - 27-04-2017
Kedrion Biopharma joins IPOPI in celebrating World PI Week 2017
Global campaign to improve early diagnosis and optimal treatments for PID
read more -
EVENTS - 14-04-2017
Kedrion Biopharma initiatives for World Hemophilia Day 2017
The goal is to provide wider access to plasma-derived therapies for coagulation disorders the world over
read more -
EVENTS - 17-10-2016
Kedrion took part in the 17th ESID Meeting with 44 international guests
The conference focused on new insights into PIDs’ diagnosis and therapies
read more -
EVENTS - 23-09-2016
Pharmaceutical digitization: how to improve patient care and engagement
Kedrion Biopharma Advisor Prof. Albert Farrugia lectures at "The Future of Science" Conference in Venice, Italy
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 